A method of separating a composition containing at least one organofluorine compound from at least one inorganic compound by contacts the composition with a semipermeable membrane. Other methods separate a organofluorine compound from a composition containing at least one other organofluorine compound or chlorocarbon. Methods also include isolating a single organofluorine compound from a composition comprising a mixture of organofluorine compounds, chlorocarbons, and/or inorganic compounds.

A method of separating a composition containing at least one organofluorine compound from at least one inorganic compound by contacts the composition with a semipermeable membrane. Other methods separate a organofluorine compound from a composition containing at least one other organofluorine compound or chlorocarbon. Methods also include isolating a single organofluorine compound from a composition comprising a mixture of organofluorine compounds, chlorocarbons, and/or inorganic compounds.

A chromia-based fluorination catalyst comprising at least one additional metal selected from zinc, nickel, aluminum and magnesium in which from 0.1 to 8.0% by weight of the catalyst is in the form of one or more crystalline compounds of chromium and/or one or more crystalline compounds of the at least one additional metal. The catalyst can be used in processes for producing a fluorinated hydrocarbon.

A chromia-based fluorination catalyst comprising at least one additional metal selected from zinc, nickel, aluminum and magnesium in which from 0.1 to 8.0% by weight of the catalyst is in the form of one or more crystalline compounds of chromium and/or one or more crystalline compounds of the at least one additional metal. The catalyst can be used in processes for producing a fluorinated hydrocarbon.

The invention relates to a compound of formula (I)

##STR00001##

wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

The invention relates to a compound of formula (I)

##STR00001##

wherein A.sup.1, A.sup.2 and R.sup.1 to R.sup.3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

A method for preparing a radiopharmaceutical and, specifically, a method for preparing an organic fluoride-aliphatic compound usable as a radiopharmaceutical, a method for purifying the prepared organic fluoride-aliphatic compound, and a method for preparing a radiopharmaceutical by using a cassette comprising a backdraft preventing reaction container. A method for preparing an organic fluorinated aliphatic compound includes allowing a fluorine salt to react with a leaving group-containing aliphatic compound by using a multifunctional solvent represented by the following Chemical Formula 1 to obtain an aliphatic compound labeled with [.sup.18F] fluoride substituting for the leaving group. The organic fluoride-aliphatic compound can be prepared and purified through even a simple process at high yield, high efficiency, and high purity, and the radiopharmaceutical can be safely prepared without damage to a synthetic apparatus.

A method for preparing a radiopharmaceutical and, specifically, a method for preparing an organic fluoride-aliphatic compound usable as a radiopharmaceutical, a method for purifying the prepared organic fluoride-aliphatic compound, and a method for preparing a radiopharmaceutical by using a cassette comprising a backdraft preventing reaction container. A method for preparing an organic fluorinated aliphatic compound includes allowing a fluorine salt to react with a leaving group-containing aliphatic compound by using a multifunctional solvent represented by the following Chemical Formula 1 to obtain an aliphatic compound labeled with [.sup.18F] fluoride substituting for the leaving group. The organic fluoride-aliphatic compound can be prepared and purified through even a simple process at high yield, high efficiency, and high purity, and the radiopharmaceutical can be safely prepared without damage to a synthetic apparatus.

The present invention provides a method for separating HFC-245cb and (E)-HFO-1234ze having close boiling points, i.e., boiling points with only 1° C. difference, by extractive distillation from a composition containing the HFC-245cb and the (E)-HFO-1234ze. More specifically, the present invention is a method for separating HFC-245cb and (E)-HFO-1234ze from a composition containing the HFC-245cb and the (E)-HFO-1234ze, the method comprising subjecting the composition to extractive distillation using at least one extractant selected from the group consisting of halogenated hydrocarbons, halogenated unsaturated hydrocarbons, nitriles, ketones, carbonates, alcohols, hydrocarbons, esters and ethers.

The present invention provides a method for separating HFC-245cb and (E)-HFO-1234ze having close boiling points, i.e., boiling points with only 1° C. difference, by extractive distillation from a composition containing the HFC-245cb and the (E)-HFO-1234ze. More specifically, the present invention is a method for separating HFC-245cb and (E)-HFO-1234ze from a composition containing the HFC-245cb and the (E)-HFO-1234ze, the method comprising subjecting the composition to extractive distillation using at least one extractant selected from the group consisting of halogenated hydrocarbons, halogenated unsaturated hydrocarbons, nitriles, ketones, carbonates, alcohols, hydrocarbons, esters and ethers.